For immediate release |
15 September 2010 |
Oxford BioMedica Plc
Notification of Major Interest in Shares
|
|||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
Oxford BioMedica Plc |
||
2. Reason for notification (yes/no) |
|||
An acquisition or disposal of voting rights |
No |
||
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
||
An event changing the breakdown of voting rights |
|
||
Other (please specify):____Amendment (see box 13) |
Yes |
||
3. Full name of person(s) subject to notification obligation: |
Barclays PLC
|
||
4. Full name of shareholder(s) (if different from 3): |
|
||
5. Date of transaction (and date on which the threshold is crossed or reached if different): |
N/a |
||
6. Date on which issuer notified: |
14 September 2010 |
||
7. Threshold(s) that is/are crossed or reached: |
N/a |
||
8: Notified Details |
|||||||
A: Voting rights attached to shares
|
|||||||
Class/type of shares If possible use ISIN code
|
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction
|
|||||
Number of shares
|
Number of voting rights
|
Number of shares
|
Number of voting rights |
Percentage of voting rights |
|||
Direct |
Indirect |
Direct |
Indirect |
||||
GB0006648157
|
N/a |
N/a |
|
|
Below notifiable threshold |
|
Below notifiable threshold |
B: Financial Instruments
|
||||
Resulting situation after the triggering transaction
|
||||
Type of financial instrument |
Expiration date |
Exercise/ conversion period/date |
No. of voting rights that may be acquired (if the instrument exercised/converted) |
Percentage of voting rights |
|
|
|
|
|
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
|
||||
Resulting situation after the triggering transaction
|
||||
Type of financial instrument |
Expiration date |
Exercise/ conversion period/date |
No. of voting rights that may be acquired (if the instrument exercised/converted) |
Percentage of voting rights |
|
|
|
|
|
Total (A+B+C)
|
|
Number of voting rights |
Percentage of voting rights |
Below notifiable threshold |
Below notifiable threshold |
9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable: |
|
Proxy Voting: |
|
10. Name of proxy holder:
|
|
11. Number of voting rights proxy holder will cease to hold:
|
|
12. Date on which proxy holder will cease to hold voting rights:
|
|
13. Additional information:
|
We have been advised that the interest disclosed in Barclays' previous Notification of Major Interests in Shares was subject to an exemption within the Disclosure and Transparency Rules and therefore did not require notification. Consequently, Barclays plc does not have a reportable interest in this issuer. |
14 Contact name:
|
Andrew Wood |
15. Contact telephone name:
|
01865 783000 |